O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.

doi:10.4103/0973-1482.200745

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

O-6-methylguanine-DNA methyltransferase gene promoter methylation and lung cancer risk: A meta-analysis.

Journal of cancer research and therapeutics - 1 Dec 2016

Yang Zhijia, Li Fangjun

Abstract excerpt

OBJECTIVE: To evaluate O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation pattern in tumor tissue and autologous controls (plasma, normal lung tissue, and bronchial lavage fluid [BLF]) in patients with nonsmall cell lung cancer (NSCLC). MATERIALS AND METHODS: We electronic searched the MEDLINE and CNKI databases to find the open published studies related to MGMT gene promoter...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to Genetic Predisposition to Disease
Share to Lung Neoplasms
Share to O(6)-Methylguanine-DNA Methyltransferase
Share to Odds Ratio
Share to Promoter Regions, Genetic
Share to Publication Bias
Share to Risk

Source

Open in PubMed

Identifiers

PMID: 28230024
DOI: 10.4103/0973-1482.200745

Genes

MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics